company background image
PHIL

Philadelphia Pharmaceuticals ASE:PHIL Stock Report

Last Price

د.أ1.28

Market Cap

د.أ9.6m

7D

0%

1Y

-6.6%

Updated

02 Dec, 2022

Data

Company Financials
PHIL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends1/6

PHIL Stock Overview

Philadelphia Pharmaceuticals PLC develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan.

Philadelphia Pharmaceuticals PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Philadelphia Pharmaceuticals
Historical stock prices
Current Share Priceد.أ1.28
52 Week Highد.أ1.50
52 Week Lowد.أ1.28
Beta0.19
1 Month Change-4.48%
3 Month Change-10.49%
1 Year Change-6.57%
3 Year Change-17.95%
5 Year Change-17.42%
Change since IPO83.91%

Recent News & Updates

Recent updates

Shareholder Returns

PHILJO PharmaceuticalsJO Market
7D0%0.9%1.1%
1Y-6.6%-2.6%21.0%

Return vs Industry: PHIL underperformed the JO Pharmaceuticals industry which returned -2.6% over the past year.

Return vs Market: PHIL underperformed the JO Market which returned 21% over the past year.

Price Volatility

Is PHIL's price volatile compared to industry and market?
PHIL volatility
PHIL Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement3.8%
10% most volatile stocks in JO Market6.4%
10% least volatile stocks in JO Market1.9%

Stable Share Price: Insufficient data to determine PHIL's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine PHIL's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993152Kayed Gazi Al-Shaabanihttps://www.philapharma.com

Philadelphia Pharmaceuticals PLC develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan. The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti-pruritic, anti-viral, plain antifungal and anti-infective, plain steroid, steroids with antifungal/anti-infective combination, and skin recoloring products. It also offers products for women health, such as vaginal antifungals, alkalinizing and cleansing agents, antimicrobials, germicidal fungicidal, antiseptics and hemostatic, and vaginal progesterone; and products in the areas of alimentary, gastrointestinal system, anti-inflammatory, analgesic, antipyretic, dental-oropharyngeal, hair care, local anesthetics, and respiratory system, as well as supplements and health care-OTC products.

Philadelphia Pharmaceuticals PLC Fundamentals Summary

How do Philadelphia Pharmaceuticals's earnings and revenue compare to its market cap?
PHIL fundamental statistics
Market Capد.أ9.60m
Earnings (TTM)-د.أ125.63k
Revenue (TTM)د.أ6.09m

1.6x

P/S Ratio

-76.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PHIL income statement (TTM)
Revenueد.أ6.09m
Cost of Revenueد.أ3.47m
Gross Profitد.أ2.63m
Other Expensesد.أ2.75m
Earnings-د.أ125.63k

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.017
Gross Margin43.10%
Net Profit Margin-2.06%
Debt/Equity Ratio20.2%

How did PHIL perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

n/a

Payout Ratio